TCI Wealth Advisors’s Flexion Therapeutics, Inc. FLXN Stock Holding History

TCI Wealth Advisors’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-591	Closed	-$4K	–	2636
2021 Q3	$4K	Buy	+591	New	+$3.68K	﹤0.01%	1881

TCI Wealth Advisors's FLXN Position: Q4 2021 in Review

TCI Wealth Advisors sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 591 shares — an estimated $4K sold.

TCI Wealth Advisors first reported a position in FLXN in Q3 2021 and held it in 1 quarter. The position peaked at $4K in Q3 2021. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

TCI Wealth Advisors reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
TCI Wealth Advisors sold 591 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $4K.
TCI Wealth Advisors first reported a position in Flexion Therapeutics, Inc. in Q3 2021 and held it in 1 quarter.
TCI Wealth Advisors's Flexion Therapeutics, Inc. position peaked at $4K in Q3 2021.
1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on TCI Wealth Advisors's 13F filing for Q4 2021, filed 24 Jan 2022.